SCP
THC icon

Steamboat Capital Partners’s Tenet Healthcare THC Stock Holding History

Steamboat Capital Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8M Buy
79,074
+29,490
+59% +$5.42M 3.16% 8
2026
Q1 		$9.36M Sell
49,584
-1,742
-3% -$367K 2.32% 18
2025
Q4 		$10.2M Buy
51,326
+110
+0.2% +$22.2K 2.8% 11
2025
Q3 		$10.4M Buy
51,216
+2,075
+4% +$368K 2.71% 13
2025
Q2 		$8.65M Sell
49,141
-50,374
-51% -$7.58M 2.46% 16
2025
Q1 		$13.4M Buy
99,515
+10,281
+12% +$1.35M 4.05% 6
2024
Q4 		$11.3M Sell
89,234
-1,278
-1% -$190K 3.48% 10
2024
Q3 		$15M Buy
90,512
+512
+0.6% +$77.4K 4.74% 8
2024
Q2 		$12M Sell
90,000
-9,937
-10% -$1.2M 4.39% 7
2024
Q1 		$10.5M Buy
99,937
+13,148
+15% +$1.18M 3.62% 10
2023
Q4 		$6.56M Sell
86,789
-13,997
-14% -$887K 2.46% 19
2023
Q3 		$6.64M Buy
100,786
+1,673
+2% +$125K 2.46% 18
2023
Q2 		$8.07M Sell
99,113
-25,887
-21% -$1.84M 2.78% 17
2023
Q1 		$7.43M Buy
+125,000
New +$6.95M 2.46% 19

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Steamboat Capital Partners's THC Position: Q2 2026 in Review

Steamboat Capital Partners increased its Tenet Healthcare (THC) stake by 59% in Q2 2026, buying an estimated $5.42M and bringing the position to 79,074 shares worth $14.8M. The position accounts for 3.16% of the portfolio, ranked #8.

Steamboat Capital Partners first reported a position in THC in Q1 2023 and has held it in 14 quarters since. The position peaked at $15M in Q3 2024. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Steamboat Capital Partners held 79,074 shares of Tenet Healthcare worth $14.8M as of Q2 2026.
  • Steamboat Capital Partners bought 29,490 Tenet Healthcare shares in Q2 2026, an estimated $5.42M.
  • Tenet Healthcare made up 3.16% of Steamboat Capital Partners's portfolio in Q2 2026, its #8 holding.
  • Steamboat Capital Partners first reported a position in Tenet Healthcare in Q1 2023 and has held it in 14 quarters since.
  • Steamboat Capital Partners's Tenet Healthcare position peaked at $15M in Q3 2024.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Steamboat Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.